Table 1. Properties and function of soluble signals involved in endochondral ossification.
Soluble Signal | Molecular weight (Da) | Biological function | Typical concentration in cell culture | Calculated isoelectric point (IP) |
---|---|---|---|---|
WNT agonist | 350 | Synthetic agonist on the Wnt pathway [36] | 0.25 μg/ml | |
Purmorphamine | 521 | Synthetic agonist on the Hh pathway [37–39] | 0.5 μg/ml | |
rhWNT3A | 37,400 | Acting on the Wnt pathway [40,41] | 5–200 ng/ml | 8.46 |
rhFGF2 | 16,400 | Inhibits chondrocyte proliferation and facilitates hypertrophy during EO [42] | 1–10 ng/ml | 9.59 |
rhVEGF | 19,000 | Permits vascularization of cartilage [43] | 1–10 ng/ml | 9.01 |
rhBMP4 | 13,100 | Acting on the TGF-ß pathway and acts during bone formation [44,45] | 1–50 ng/ml | 7.60 |